Post-Trade Analysis: CVS Health Corp (CVS) Climbs 1.60, Closing at 67.85

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

After finishing at $66.78 in the prior trading day, CVS Health Corp (NYSE: CVS) closed at $67.85, up 1.60%. In other words, the price has increased by $1.60 from its previous closing price. On the day, 9.93 million shares were traded.

Ratios:

Our goal is to gain a better understanding of CVS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.45. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.82. In the meantime, Its Debt-to-Equity ratio is 1.06 whereas as Long-Term Debt/Eq ratio is at 0.96.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on February 13, 2025, Upgraded its rating to Outperform and sets its target price to $75 from $55 previously.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 02 ’25 when ROBBINS LARRY sold 2,276,068 shares for $67.86 per share. The transaction valued at 154,444,758 led to the insider holds 9,670,731 shares of the business.

ROBBINS LARRY sold 1,323,932 shares of CVS for $89,249,945 on May 05 ’25. The Director now owns 8,346,799 shares after completing the transaction at $67.41 per share. On May 06 ’25, another insider, ROBBINS LARRY, who serves as the Director of the company, sold 150,000 shares for $66.67 each. As a result, the insider received 10,000,710 and left with 8,196,799 shares of the company.

Valuation Measures:

As of this moment, CVS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.21, and their Forward P/E ratio for the next fiscal year is 9.65. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.14. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.23 while its Price-to-Book (P/B) ratio in mrq is 1.11.

Stock Price History:

Over the past 52 weeks, CVS has reached a high of $72.51, while it has fallen to a 52-week low of $43.56. The 50-Day Moving Average of the stock is 1.72%, while the 200-Day Moving Average is calculated to be 14.53%.

Shares Statistics:

A total of 1.27B shares are outstanding, with a floating share count of 1.26B. Insiders hold about 0.15% of the company’s shares, while institutions hold 84.29% stake in the company.

Most Popular